Evidence map›Paper›PMID 40499542›Full record

ArticleCell2025

Unraveling mitochondrial influence on mammalian pluripotency via enforced mitophagy.

Daniel A Schmitz, Seiya Oura, Leijie Li, Yi Ding, Rashmi Dahiya, Emily Ballard, Carlos Pinzon-Arteaga, Masahiro Sakurai, Daiji Okamura, Leqian Yu and 2 more

Abstract read
In one paragraph

Article in Cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. The making of cells and organs in xenogeneic animal bioreactor.Signal transduction and targeted therapy · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Thyroid hormones, mitochondria, aging, and cancer.Frontiers in endocrinology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel A SchmitzDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Seiya OuraDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Leijie LiDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Yi DingDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Rashmi DahiyaDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Emily BallardDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Carlos Pinzon-ArteagaDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Masahiro SakuraiDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Daiji OkamuraDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Advanced Bioscience, Faculty of Agriculture, Kindai University, Nara, Japan.
Leqian YuDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Peter LyDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Jun WuDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: jun2.wu@utsouthwestern.edu.

Funding

Dissect the mechanisms underlying interspecies pluripotent stem cell competitionR01HD103627 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI Michael Buszczak, Ondine B Cleaver · 2022 to 2026
$1.8M
Dissect formative pluripotency using cultured pluripotent stem cellsR01GM138565 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI WU, JUN · 2021 to 2025
$1.7M
TEM for UT Southwestern Electron Microscopy Core FacilityS10OD021685 · OD · UT SOUTHWESTERN MEDICAL CENTER · PI LUBY-PHELPS, KATHERINE J · 2017 to 2017
$398k
Study of mitochondria-depleted pluripotent stem cells in development and diseaseF31NS125906 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI SCHMITZ, DANIEL ANDREW · 2022 to 2023
$70k
NICHD NIH HHS R01 HD103627NIGMS NIH HHS R01 GM138565NIH HHS S10 OD021685NINDS NIH HHS F31 NS125906
6 · The paper itself

Abstract

Mitochondrial abundance and genome are crucial for cellular function, with disruptions often associated with disease. However, methods to modulate these parameters for direct functional dissection remain limited. Here, we eliminate mitochondria from pluripotent stem cells (PSCs) by enforced mitophagy and show that PSCs survived for several days in culture without mitochondria. We then leverage enforced mitophagy to generate interspecies PSC fusions that harbor either human or non-human hominid (NHH) mitochondrial DNA (mtDNA). Comparative analyses indicate that human and NHH mtDNA are largely interchangeable in supporting pluripotency in these PSC fusions. However, species divergence between nuclear and mtDNA leads to subtle species-specific transcriptional and metabolic variations. By developing a transgenic enforced mitophagy approach, we further show that reducing mitochondrial abundance leads to delayed development in pre-implantation mouse embryos. Our study opens avenues for investigating the roles of mitochondria in development, disease, and interspecies biology.

Indexed as

MitochondriaMitophagyPluripotent Stem CellsAnimalsDNA, MitochondrialHumansMiceSpecies SpecificityDNA, Mitochondrialcell fusiongreat apesinterspecies compositeinterspecies hybridmetabolismmitochondriamitophagymtDNApluripotent stem cells

Identifiers

PMID40499542
PMCPMC12354063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.